期刊文献+

不同治疗方案对浸润性突眼的疗效及临床特点 被引量:7

下载PDF
导出
摘要 目的探讨不同治疗方案对浸润性突眼的疗效及临床特点。方法将就诊的176例浸润性突眼患者分为3组,分别应用不同的治疗方案:强的松治疗、硫唑嘌呤治疗、强的松+硫唑嘌呤治疗。探讨不同治疗方案与疗效、疗程、影响突眼疗效相关因素的关系。结果强的松+硫唑嘌呤治疗组疗效最好(P<0.05),且两药有协同作用。眼部病变活动度高者,疗效好于眼部病变活动度低者(P<0.05)。结论病情的改善与眼部病变活动度有关,强的松和硫唑嘌呤联合用药是治疗浸润性突眼的有效方法。
出处 《广东医学》 CAS CSCD 北大核心 2013年第12期1920-1922,共3页 Guangdong Medical Journal
  • 相关文献

参考文献12

  • 1BARTLEY G B, GORMAN C V. Diagnostic criteria for Graves' ophthalmopathy[ J]. Am J Ophthalmol, 1995, 119 ( 6 ) : 792 - 795.
  • 2WERNER S C. Modification of the classification of the eye chan- ges of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association [ J ]. J Clin Endocrinol Metab, 1977, 44( 1 ) : 203 - 204.
  • 3HENRY M, KRONENBERG M D. Williams textbooks of endocri- nology[M], llth ed. Phidadelphia: Saunders Co, 2008:333 - 375.
  • 4MOURITS M P, PRUMMEL M F, WIERSINGA W M, et al. Clinical Activity Score as aguide in the management of patients with Graves' ophthalmopathy [ J ]. Clin Endocrinol (Oxf) , 1997, 47(1):9-14.
  • 5ARDLEY M, MCCORQUODALE T, LAHOOTI H, et al. Eye findings and immunological markers in probands and their euthy- mid relatives from a single family with muhiple cases of thyroid au- toimmunity[ J]. Thyroid, 2012, 5 (1):4.
  • 6TEKTONIDOU M G, ANAPLIOTOU M, VALCHOYIANNO- PLOULOS P, et al. Presence of systemic autonimmun disorders in patients with in systemic autonimmun thyroid diseases [ J ]. Ann Rheum Dis, 2004, 63(9) : 1159 - 1161.
  • 7杨明功.浸润性突眼的诊断及治疗进展[J].安徽医科大学学报,2001,36(2):83-86. 被引量:3
  • 8白耀.甲状腺功能亢进症[M]∥史轶蘩.协和内分泌和代谢学.北京:科学出版社,1999:1019-1051.
  • 9COLE M, MITCHELL S, PAISEY R, et al. Recognising and trea- ting thyroid - associated ophthalmopathy[ J]. Practitioner, 1995, 239(1549) : 261 -263.
  • 10KRASSAS G E, HEUFELDER A E. Immunosuppressive therapy in patients with thyroid eye disease: an overview of current con- cepts[J]. Eur J Endocrinol, 2001, 144(4) : 311 -318.

二级参考文献5

  • 1陈灏珠.实用内科学(上册)第10版[M].北京:人民卫生出版社,1998.646-648.
  • 2Bahn RS,Dutton CM, Heufelder AE ed al.A genomic point mutation in the extracellulardomain of the thyrotropin receptor in patients with Graves' ophthalmopathy. J ClinEndocrinol Metab,1994;78(2):256~260
  • 3Wilson JD,Foster DW,Kronenberg HM et al. Willams Textbook of Endocrinology.9th ed,Philadelphia: WB Saunders Company,1998:389~498
  • 4朱显军,安振梅,魏松全.促甲状腺激素受体在Graves眼病发病中的作用研究进展[J].国外医学(内分泌学分册),2000,20(4):179-182. 被引量:5
  • 5张天钧.Graves眼病的诊断及治疗[J].中华内分泌代谢杂志,2000,16(3):196-197. 被引量:11

共引文献2

同被引文献24

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部